The link IFN-γ and allograft arteriopathy: Is the answer no?

Journal of Clinical Investigation

Volumn 114, Issue 6, 2004, Pages 762-764

  Mitchell, Richard N ^a   Lichtman, Andrew H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ALLOGRAFT; ARTERY DISEASE; CORRELATION FUNCTION; ENZYME ACTIVITY; GRAFT REJECTION; HUMAN; IMMUNOPATHOGENESIS; INTERFERON PRODUCTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VASCULAR SMOOTH MUSCLE;

ARTERIES; HUMANS; INTERFERON TYPE II; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; TRANSPLANTATION, HOMOLOGOUS;

EID: 9644307940     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200422927     Document Type: Review

References (19)

1. Mitchell, R.N. 2004. Allograft artetiopathy: pathogenesis update. Cardiovasc. Pathol. 13:33-40.
2. Nagano, H., et al. 1997. Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J. Clin. Invest. 100:550-557.
3. Raisanen-Sokolowski, A., Glysing-Jensen, T., Koglin, J., and Russell, M.E. 1998. Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients. Am. J. Pathol. 152:359-365.
4. Russell, P.S., Chase, C.M., Winn, H.J., and Colvin, R.B. 1994. Coronary atherosclerosis in transplanted mouse hearts. III. Effects of recipient treatment with a monoclonal antibody to interferon-gamma. Transplantation. 57:1367-1371.
5. Choi, J., Enis, D.R., Koh, K.P., Shiao, S.L., and Pober, J.S. 2004. T lymphocyte-endothelial cell interactions. Annu. Rev. Immunol. 22:683-709.
6. Lorber, M.I., et al. 1999. Human allogeneic vascular rejection after arterial transplantation and peripheral lymphoid reconstitution in severe combined immunodeficient mice. Transplantation. 67:897-903.
7. Tellides, G., et al. 2000. Interferon-[gamma] elicits arteriosclerosis in the absence of leukocytes. Nature. 403:207-211.
8. Wang, Y., et al. 2004. Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries. FASEB J. 18:606-608.
9. Liu, Z., et al. 1998. Nitric oxide and endothelin in the development of cardiac allograft vasculopathy. Potential targets for therapeutic interventions. Atherosclerosis. 140:1-14.
10. Behrendt, D., Ganz, P., and Fang, J.C. 2000. Cardiac allograft vasculopathy. Curr. Opin. Cardiol. 15:422-429.
11. Davignon, J., and Ganz, P. 2004. Role of endothelial dysfunction in atherosclerosis. Circulation. 109(Suppl. 1):III-27-III-32.
12. Koh, K.P., et al. 2004. T cell-mediated vascular dysfunction of human allografts results from IFN-γ dysregulation of NO synthase. J. Clin. Invest. 114:846-856. doi:10.1172/JC1200421767.
13. Cornwell, T.L., Arnold, E., Boerth, N.J., and Lincoln, T.M. 1994. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am. J. Physiol. 267:C140S-C1413.
14. Koglin, J., Glysing-Jensen, T., Mudgett, J.S., and Russell, M.E. 1998. Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice. Circulation. 97:2059-2065.
15. kipl-dependent mechanism. J. Clin. Invest. 114:419-426. doi:10.1172/JCI200420176.
16. Mazanet, MM., and Hughes, C.C. 2002. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J. Immunol. 169:3581-3588.
17. Rodig, N., et al. 2003. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur. J. Immunol. 33:3117-3126.
18. Nagano, H., et al. 1998. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma. Am. J. Pathol. 152:1187-1197.
19. Miura, M., El-Sawy, T., and Fairchild, R.L. 2003. Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-gamma. Am. J. Pathol. 162:509-519.